Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 957 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experienceKeefe, D.; Lees, J.; Horvath, N.
2001Evaluation of hand function in patients undergoing long term haemodialysisLimaye, V.; Frankham, A.; Disney, A.; Pile, K.
1998LDL particle size and LDL and HDL cholesterol changes with dietary fat and cholesterol in healthy subjectsClifton, P.; Noakes, M.; Nestle, P.
2002Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancerRicciardelli, C.; Brooks, J.; Suwiwat, S.; Sakko, A.; Mayne, K.; Raymond, W.; Seshadri, R.; LeBaron, R.; Horsfall, D.
2003Responses of single motor units in human masseter to transcranial magnetic stimulation of either hemispherePearce, S.; Miles, T.; Thompson, P.; Nordstrom, M.
1996Gastric emptying in "early" non-insulin dependent diabetes mellitusJones, K.; Horowitz, M.; Carney, B.; Wishart, J.; Guha, S.; Green, L.
1995Changes in the polyunsaturated fatty-acids of breast-milk from mothers of full-term infants over 30 wk of lactationMakrides, M.; Simmer, K.; Neumann, M.; Gibson, R.
1998Oil blends containing partially hydrogenated or interesterified fats: differential effects on plasma lipidsNoakes, M.; Clifton, P.
2010Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver diseaseDongiovanni, P.; Valenti, L.; Rametta, R.; Daly, A.; Nobili, V.; Mozzi, E.; Leathart, J.; Pietrobattista, A.; Burt, A.; Maggioni, M.; Fracanzani, A.; Lattuada, E.; Zappa, M.; Roviaro, G.; Marchesini, G.; Day, C.; Fargion, S.
2002High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceBranford, S.; Rudzki, Z.; Walsh, S.; Grigg, A.; Arthur, C.; Taylor, K.; Herrmann, R.; Lynch, K.; Hughes, T.